SCHEMBL12437619

SCHEMBL12437619

O=C(O)[C@H]1NC2CC[C@H]1C2

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLC1A2 P43004 2/20 0.42
▸ SLC1A1 P43005 1/20 0.42
▸ PKM P14618 1/20 0.39
▸ BLM P54132 3/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ PMP22 Q01453 1/20 0.39
▸ CTSC P53634 7/20 0.37
▸ ATM Q13315 1/20 0.36
▸ CHRNA7 P36544 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21151866 1.00 SLC1A2 (0.42) SLC1A2SLC1A1PKMBLMCYP2D6
SCHEMBL29952931 1.00 SLC1A2 (0.42) SLC1A2SLC1A1PKMBLMCYP2D6
SCHEMBL6480162 1.00 SLC1A2 (0.42) SLC1A2SLC1A1PKMBLMCYP2D6
SCHEMBL4040707 1.00 SLC1A2 (0.42) SLC1A2SLC1A1PKMBLMCYP2D6
SCHEMBL6479236 1.00 SLC1A2 (0.42) SLC1A2SLC1A1PKMBLMCYP2D6
SCHEMBL993042 1.00 SLC1A2 (0.42) SLC1A2SLC1A1PKMBLMCYP2D6
Hydrochloric Acid SCHEMBL11149903 0.98 SLC1A2 (0.41) SLC1A2SLC1A1PKMBLMCYP2D6
Hydrochloric Acid SCHEMBL8385290 0.98 SLC1A2 (0.41) SLC1A2SLC1A1PKMBLMCYP2D6
Hydrochloric Acid SCHEMBL2157333 0.98 SLC1A2 (0.41) SLC1A2SLC1A1PKMBLMCYP2D6
Hydrochloric Acid SCHEMBL19064846 0.98 SLC1A2 (0.41) SLC1A2SLC1A1PKMBLMCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3917944-A1 THERAPEUTIC PEPTIDES Cohbar Inc. (US) 2021-12-08 — — EP disclosed
WO-2020160003-A1 THERAPEUTIC PEPTIDES COHBAR, INC. (US) 2020-08-06 — — WO disclosed
EP-3634978-A1 TAU AGGREGATION INHIBITORS Adrx, Inc. (US) 2020-04-15 — — EP disclosed
WO-2018226992-A1 TAU AGGREGATION INHIBITORS ADRX, INC. (US) 2018-12-13 — — WO disclosed
WO-2011091532-A1 HEPATITIS C INHIBITOR COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-08-04 — — WO disclosed
Send feedback